Search results for "bispecific"

Article Detailed agenda for Chromatography + filtration virtual summit
Explore the latest advancements in process development and scale-up Check out the full agenda below! Join Cytiva Chromatography and filtration summit online to learn from presentatio…

Article Register to the Chromatography + Filtration Virtual Summit 2024
Explore the latest advancements in process development and scale-up 5-7 March, 2024 - 15:00 - 18:00 CET all 3 days Join Cytiva Chromatography and filtration summit online to lear…

Article Exploring the world of antibodies: mAbs, Fabs, dAbs, and bsAbs
There is a vast array of antibody variants, including multispecific (msAb), bispecific antibodies (bsAb), antibody fragments (Fab, dAb, scFv), and antibody-drug conjugates (ADC). But with this…

Webcast Peptalk 2024 – San Diego
Conference tracks cover a range of topics including antibody engineering, bispecific antibody development, characterization of biologics, viral vector engineering, and protein expression platforms. Le…

Article Fundamentals of hydrophobic interaction chromatography
… molecules:  * recombinant proteins and peptides  * monoclonal antibodies (mAbs), bispecific mAbs and antibody-drug conjugates (ADC) * mRNA * plasmid  New to HIC? Browse this …

Article Antibody purification quiz
How well do you know antibodies and antibody purification? Test your knowledge and gain insights in the purification of antibody variants – bsAbs, Fab, dAbs.

Article Pushing the Barriers in Next-Gen Antibody Development
Continued development of new and next-generation antibodies is spurred by the increasing demand for more effective and custom-tailored biologic therapies. In particular, bispecific antibodi…

Article Protein L affinity resin is ready to move to manufacturing
Although protein L affinity resins have been available for more than a decade, insufficient binding capacities and alkaline stability challenges have limited their use in productive manufactur…

Article Enhancing Resins Addresses Purification Concerns
Existing challenges Beyond vaccines, biotherapeutic development is seeing the emergence of a variety of other complex modalities, such as bispecific antibodies and protein fragments in addition …

Article Antibody Production Workflow
Explore the workflow here >> Antibody-based therapies have evolved beyond monoclonal antibodies (mAbs) to include bispecific antibodies, antibody fragments, antibody-drug conjugates (ADCs), and m…

Previous PageNext Page